Your browser doesn't support javascript.
loading
Corneal confocal microscopy demonstrates varying degrees of neurodegeneration in atypical parkinsonian disorders.
Lim, Sze Hway; Ferdousi, Maryam; Bhattacharjee, Shakya; Kalteniece, Alise; Mahfoud, Ziyad R; Petropoulos, Ioannis N; Malik, Rayaz A; Kobylecki, Christopher; Silverdale, Monty.
Afiliación
  • Lim SH; Department of Neurology, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.
  • Ferdousi M; Faculty of Biology, Medicine and Health, Division of Cardiovascular Sciences, University of Manchester, Manchester, UK.
  • Bhattacharjee S; Department of Neurology, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK. Electronic address: bubai.shakya@gmail.com.
  • Kalteniece A; Faculty of Biology, Medicine and Health, Division of Cardiovascular Sciences, University of Manchester, Manchester, UK.
  • Mahfoud ZR; Weill Cornell Medicine-Qatar, Doha, Qatar.
  • Petropoulos IN; Weill Cornell Medicine-Qatar, Doha, Qatar.
  • Malik RA; Faculty of Biology, Medicine and Health, Division of Cardiovascular Sciences, University of Manchester, Manchester, UK; Weill Cornell Medicine-Qatar, Doha, Qatar.
  • Kobylecki C; Department of Neurology, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.
  • Silverdale M; Department of Neurology, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.
Parkinsonism Relat Disord ; 117: 105899, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37948830
OBJECTIVE: We have used corneal confocal microscopy (CCM) to identify corneal nerve loss as a potential marker of neurodegeneration in participants with Parkinson's disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). METHODS: Patients with PD (n = 19), PSP (n = 11), MSA (n = 8) and healthy controls (n = 18) underwent neurological assessment and CCM. RESULTS: Corneal nerve fibre density was significantly lower in participants with PD (p = 0.005), PSP (p = 0.005) and MSA (p = 0.0003) compared to controls. Corneal nerve branch density was significantly lower in participants with PD (p = 0.01) and MSA (p = 0.019), but not in participants with PSP (p = 0.662), compared to controls. Corneal nerve fibre length was significantly lower in participants with PD (p = 0.002) and MSA (p = 0.001) but not in participants with PSP (p = 0.191) compared to controls. CONCLUSION: CCM detects corneal nerve loss in participants with PD and MSA and to a lesser extent in PSP compared to healthy controls.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Parálisis Supranuclear Progresiva / Atrofia de Múltiples Sistemas / Trastornos Parkinsonianos Límite: Humans Idioma: En Revista: Parkinsonism Relat Disord Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Parálisis Supranuclear Progresiva / Atrofia de Múltiples Sistemas / Trastornos Parkinsonianos Límite: Humans Idioma: En Revista: Parkinsonism Relat Disord Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido